Buclizine

Buclizine
Clinical data
AHFS/Drugs.com Micromedex Detailed Consumer Information
ATC code R06AE01 (WHO)
Identifiers
CAS Number 82-95-1 YesY
PubChem (CID) 6729
IUPHAR/BPS 7134
DrugBank DB00354 YesY
ChemSpider 6473 YesY
UNII 0C94V6X681 YesY
ChEBI CHEBI:3205 YesY
ChEMBL CHEMBL1201271 N
ECHA InfoCard 100.001.317
Chemical and physical data
Formula C28H33ClN2
Molar mass 433.028 g/mol
3D model (Jmol) Interactive image
Chirality Racemic mixture
 NYesY (what is this?)  (verify)

Buclizine is an antihistamine and anticholinergic of the piperazine derivative family. It is considered to be an antiemetic, similar to meclizine.[1]

In the United Kingdom, buclizine is one of three drugs contained in Migraleve tablets, marketed by McNeil Healthcare at migraine sufferers.[2]

References

  1. Mostafa, G. A. E.; Al-Badr, A. A. (2011). "Buclizine". Profiles of drug substances, excipients, and related methodology. Profiles of Drug Substances, Excipients and Related Methodology. 36: 1–33. doi:10.1016/B978-0-12-387667-6.00001-4. ISBN 9780123876676. PMID 22469258.
  2. Behrendt, W. A.; Cserepes, J. (1985). "Acute toxicity and analgesic action of a combination of buclizine, codeine and paracetamol ('Migraleve') in tablet and suppository form in rats". Pharmatherapeutica. 4 (5): 322–331. PMID 4070325.


This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.